National Guideline Clearinghouse | Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.

full-text ►
National Guideline Clearinghouse | Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.

Guideline Title

Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.

 

 

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer. London (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Aug. 48 p. (Technology appraisal guidance; no. 263).

  Advanced breast cancer overview - NICE Pathways

 

Guideline Status

This is the current release of the guideline.